Kazia Therapeutics Limited

NASDAQ: KZIA
Share price (12/23/24): $2.97
Market cap (12/23/24): $9.886 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/24 FY 2024

Late filing notification for annual report of foreign issuer

ended 06/30/23 FY 2023

ended 06/30/22 FY 2022

ended 06/30/21 FY 2021

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Prospectus supplement

Prospectus supplement

Updated info for already-effective prospectus

Ownership Filter

Armistice Capital, LLC

Platinum Investment Management Ltd

Alumni Capital LP

Alumni Capital LP

Armistice Capital, LLC

News Filter

To Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium

Material disclosure

Announces Granting of Type C Meeting With FDA to Discuss Potential Next Steps for Paxalisib in the Treatment of Newly Diagnosed Glioblastoma Multiforme

Material disclosure – amended

Material disclosure

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC